163 related articles for article (PubMed ID: 8392699)
21. Beta 3 integrin derived peptide 217-230 inhibits fibrinogen binding and platelet aggregation: significance of RGD sequences and fibrinogen A alpha-chain.
Lasz EC; McLane MA; Trybulec M; Kowalska MA; Khan S; Budzynski AZ; Niewiarowski S
Biochem Biophys Res Commun; 1993 Jan; 190(1):118-24. PubMed ID: 8422238
[TBL] [Abstract][Full Text] [Related]
22. Creatine phosphate in rat platelets decreased by ADP or thrombin.
Shibata S
Thromb Haemost; 1979 Aug; 42(2):626-30. PubMed ID: 505370
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the effects of PAR1 antagonists, PAR4 antagonists, and their combinations on thrombin-induced human platelet activation.
Wu CC; Teng CM
Eur J Pharmacol; 2006 Sep; 546(1-3):142-7. PubMed ID: 16890935
[TBL] [Abstract][Full Text] [Related]
24. Effects of DK-002, a synthesized (6aS,cis)-9,10-Dimethoxy-7,11b-dihydro-indeno[2,1-c]chromene-3,6a-diol, on platelet activity.
Lee KS; Khil LY; Chae SH; Kim D; Lee BH; Hwang GS; Moon CH; Chang TS; Moon CK
Life Sci; 2006 Feb; 78(10):1091-7. PubMed ID: 16153663
[TBL] [Abstract][Full Text] [Related]
25. Clopidogrel inhibits platelet-leukocyte interactions and thrombin receptor agonist peptide-induced platelet activation in patients with an acute coronary syndrome.
Xiao Z; Théroux P
J Am Coll Cardiol; 2004 Jun; 43(11):1982-8. PubMed ID: 15172401
[TBL] [Abstract][Full Text] [Related]
26. Effect of SR121566A, a potent GP IIb-IIIa antagonist on platelet-mediated thrombin generation in vitro and in vivo.
Herault JP; Peyrou V; Savi P; Bernat A; Herbert JM
Thromb Haemost; 1998 Feb; 79(2):383-8. PubMed ID: 9493595
[TBL] [Abstract][Full Text] [Related]
27. P2Y1-receptors in human platelets which are pharmacologically distinct from P2Y(ADP)-receptors.
Fagura MS; Dainty IA; McKay GD; Kirk IP; Humphries RG; Robertson MJ; Dougall IG; Leff P
Br J Pharmacol; 1998 May; 124(1):157-64. PubMed ID: 9630355
[TBL] [Abstract][Full Text] [Related]
28. Interaction of the protein C activation peptide with platelets.
Martínez-Cruz R; Canseco Mdel S; Lopez-Martínez J; Cruz PA; Pérez-Campos E; Cruz MM; Alva FC; Majluf-Cruz A; Zenteno E; Ruiz-Argüelles A
Prep Biochem Biotechnol; 2007; 37(2):139-47. PubMed ID: 17454824
[TBL] [Abstract][Full Text] [Related]
29. Role of cytoplasmic and releasable ADP in platelet aggregation induced by laminar shear stress.
Moritz MW; Reimers RC; Baker RK; Sutera SP; Joist JH
J Lab Clin Med; 1983 Apr; 101(4):537-44. PubMed ID: 6833826
[TBL] [Abstract][Full Text] [Related]
30. Thrombin receptor agonist peptide decreases thrombomodulin activity in cultured human umbilical vein endothelial cells.
Maruyama Y; Maruyama I; Soejima Y
Biochem Biophys Res Commun; 1994 Mar; 199(3):1262-9. PubMed ID: 8147869
[TBL] [Abstract][Full Text] [Related]
31. [Effect of thrombomodulin on specific thrombin functions: fibrinogen coagulation and thrombocyte aggregation].
Luk'ianenko EF; Kireeva EG; Strukova SM
Biull Eksp Biol Med; 1988 Nov; 106(11):517-9. PubMed ID: 2848597
[TBL] [Abstract][Full Text] [Related]
32. Platelet activation by platelet aggregation factor from Eisenia foelide.
Qian R; Zhou YC; Zhuang QQ
Zhongguo Yao Li Xue Bao; 1994 Sep; 15(5):432-5. PubMed ID: 7717070
[TBL] [Abstract][Full Text] [Related]
33. Further evidence against the validity of using an ADP-removing enzyme system (CP/CPK) for demonstrating the role of secreted ADP in platelet activation.
Nunn B; Chamberlain PD
Thromb Res; 1983 Apr; 30(1):19-26. PubMed ID: 6857606
[TBL] [Abstract][Full Text] [Related]
34. Deaggregation of human platelets aggregated by thrombin.
Kinlough-Rathbone RL; Perry DW; Packham MA; Mustard JF
Thromb Haemost; 1985 Feb; 53(1):42-4. PubMed ID: 2986309
[TBL] [Abstract][Full Text] [Related]
35. Platelet-platelet recognition during aggregation: distinct mechanisms determined by the release reaction.
Agam G; Livne A
Thromb Haemost; 1984 Apr; 51(2):145-9. PubMed ID: 6740546
[TBL] [Abstract][Full Text] [Related]
36. Isolation of a peptide antagonist to the thrombin receptor using phage display.
Doorbar J; Winter G
J Mol Biol; 1994 Dec; 244(4):361-9. PubMed ID: 7990127
[TBL] [Abstract][Full Text] [Related]
37. Effects of halothane on the cyclic 3',5'-adenosine monophosphate enzyme system in human platelets.
Walter F; Vulliemoz Y; Verosky Y; Triner L
Anesth Analg; 1980 Nov; 59(11):856-61. PubMed ID: 6252800
[TBL] [Abstract][Full Text] [Related]
38. In vitro antiplatelet profile of FR171113, a novel non-peptide thrombin receptor antagonist.
Kato Y; Kita Y; Nishio M; Hirasawa Y; Ito K; Yamanaka T; Motoyama Y; Seki J
Eur J Pharmacol; 1999 Nov; 384(2-3):197-202. PubMed ID: 10611442
[TBL] [Abstract][Full Text] [Related]
39. Enzymatic removal of ADP from plasma: unaltered platelet adhesion but reduced aggregation on subendothelium and collagen fibrils.
Tschopp TB; Baumgartner HR
Thromb Haemost; 1976 Apr; 35(2):334-41. PubMed ID: 989633
[TBL] [Abstract][Full Text] [Related]
40. Reocclusion after thrombolytic therapy: strategies for inhibiting thrombin-induced platelet aggregation.
Puri RN; Colman RW
Blood Coagul Fibrinolysis; 1993 Jun; 4(3):465-78. PubMed ID: 8329574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
